Allogeneic stem cell transplant in relapsed/ refractory Hodgkin lymphoma: A 21 years’ experience

Background: Allogenic stem cell transplant (alloSCT) has been used for several decades as a salvage strategy for relapsed/ refractory Hodgkin lymphoma (R/R HL), being a durable disease control method for some patients. Methods: A unicenter retrospective analysis was performed about alloSCT in R/R HL...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto, Maria Eduarda, Vaz, Carlos Pinho, Branca, Rosa, Leite, Luís, Brás, Gil, Roncon, Susana, Campos, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194503/
https://www.ncbi.nlm.nih.gov/pubmed/37213920
http://dx.doi.org/10.1097/j.pbj.0000000000000173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194503/
https://www.ncbi.nlm.nih.gov/pubmed/37213920
http://dx.doi.org/10.1097/j.pbj.0000000000000173

Ejemplares similares